AXSM - Axsome Therapeutics Director Awarded $487K Worth of Stock Options | Benzinga
Susan Mahony, Director at Axsome Therapeutics (NASDAQ:AXSM), reported a large acquisition of company stock options on October 13, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Mahony, Director at Axsome Therapeutics, a company in the Health Care sector, was just awarded stock options worth 7,375 shares of AXSM. The options give Mahony the right to buy the company's stock at $70.56 per share.
Axsome Therapeutics shares are trading down 0.57% at $66.13 at the time of this writing on Friday morning. Since the current price is $66.13, this makes Mahony's 7,375 shares worth $487,708.